ORIGINAL ARTICLE |
|
Year : 2015 | Volume
: 11
| Issue : 42 | Page : 311-319 |
|
Effects of Pogostemon cablin Blanco extract on hypoxia induced rabbit cardiomyocyte injury
Chi-Yeon Lim1, Bu-Yeo Kim2, Se-Hyun Lim3, Su-In Cho4
1 Department of Medicine, College of Medicine, Dongguk University, Ilsan 305-701, Korea 2 Herbal Medicine Research Division, Korea Institute of Oriental Medicine, Daejeon 305-701, Korea 3 Department of Nursing, School of Public Health, Far East University, Chungbuk 369-700, Korea 4 Department of Korean Medicine, School of Korean Medicine, Pusan National University, Yangsan, Gyeongnam 626-870, Korea
Correspondence Address:
Su-In Cho School of Korean Medicine, Pusan National University, Beomeori, Mulgeum eup, Yangsan, Gyeongnam 626-870 Korea
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0973-1296.153084
|
|
Background: Pogostemonis Herba, the dried aerial part of Pogostemon cablin Blanco, is a well-known materia medica in Asia that is widely used for syndrome of gastrointestinal dysfunctions. Objective: This study was undertaken to examine whether Pogostemon cablin extract (PCe) might have any beneficial effect on hypoxia induced rabbit cardiomyocyte injury. Materials and Methods: Isolated cardiomyocytes were divided into three groups and the changes of cell viability in cardiomyocytes of hypoxic and hypoxia/reoxygenation group were determined. The effect of PCe on reactive oxygen species (ROS) generation, intracellular formation of ROS was also measured by monitoring the 2',7'- dichlorofluorescein fluorescence. Results: PCe effectively protected the cells against both the hypoxia and reoxygenation induced injury, and the protective effect of PCe is not mediated by interaction with adenosine triphosphate-sensitive K + channels. In the presence of PCe, production of ROS under chemical hypoxia was remarkably reduced which suggests that PCe might exert its effect as a ROS scavenger. Conclusion: The present study provides clear evidence for the beneficial effect of PCe on cardiomyocyte injury during hypoxia or reoxygenation following prolonged hypoxia. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|